Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 103   

Articles published

4502 4,486.00 -50.00 (-1.10%)
price chart
Japan drugmaker Takeda to fight $6 billion damages awarded by US jury
SAN FRANCISCO/TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan's largest drugmaker of concealing cancer risks associated with its ...
Takeda, Lilly Jury Awards $9 Billion Over Actos Risks  Bloomberg
Japan's Takeda to fight $6-billion damages imposed by US jury  The Globe and Mail
Related articles »  
Stocks In News: Takeda Pharmaceutical Co (OTCMKTS:TKPYY), Hooper ...
Takeda Pharmaceutical Co. Ltd (ADR) (OTCMKTS:TKPYY) lost the first federal court trial in the U.S. over claims it hid the cancer risks of its Actos diabetes medicine to protect billions of dollars in sales.
Related articles »  
Narrower of Possible Claim Constructions Prevails - Takeda Pharmaceutical Co ...
Takeda Pharmaceutical Co. Ltd. v. Zydus Pharma USA, Inc., Case No. 13-1406 (Fed. Cir., Feb. 20, 2014) (Prost, J.). Takeda Pharmaceutical and several related entities own patents claiming the formulation for the brand-name drug Prevacid´┐Ż SolutabTM, ...
Takeda Pharma says Japan approves two flu vaccine drugs
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said on Monday it had received approval to manufacture and supply two vaccines for prevention of pandemic influenza from the Japanese health ministry.
Related articles »  
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing ...
Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Head Office: Osaka, Japan) and Takeda Pharmaceutical Company Limited ("Takeda") (Head Office: Osaka, Japan) today jointly announced that the European Commission has granted Marketing Authorization ...
Takeda, Dainippon Sumitomo Get Schizophrenia Drug Approval Europe  Drug Discovery & Development
Related articles »  
Stocks Roundup - Ferrellgas Partners, L.P. (FGP), Aviva Plc (ADR) (AV), Takeda ...
Otsuka Pharmaceutical Co. Ltd and Takeda Pharmaceutical Co. Ltd. (TKPYY) have signed into a co-promotion agreement in Japan for TAK-438, a drug discovered by Takeda for the treatment of acid-related diseases, the two Japanese drugmakers said late ...
AAW Pharmaceuticals partners with global pharmaceutical leader "Takeda"
(AAW) today announced a partnership agreement with Japan-based pharmaceutical company Takeda Pharmaceutical Company Limited (Takeda), the largest pharmaceutical company in Asia, to distribute a new and wide range of high-quality pharmaceutical ...
Otsuka, Takeda To Co-promote Gastrointestinal Drug TAK-438 In Japan
Otsuka Pharmaceutical Co. Ltd and Takeda Pharmaceutical Co. Ltd. (TKPYY) have entered into a co-promotion agreement in Japan for TAK-438, a drug discovered by Takeda for the treatment of acid-related diseases, the two Japanese drugmakers said late ...
Otsuka, Takeda Sign Co-promotion Deal For TAK-438 In Japan - Quick Facts  NASDAQ
Otsuka, Takeda sign co-promotion pact in Japan for TAK-438 to treat acid ...  pharmabiz.com
Related articles »  
No Sanctions For Takeda Doc Destruction In Ill. Cancer Trial
Law360, New York (April 21, 2014, 9:41 PM ET) -- Takeda Pharmaceutical Co. Ltd. won't face sanctions for evidence destruction in the first lawsuit set for trial in Illinois that blames the diabetes drug Actos for causing bladder cancer, a state judge ...
Bellwether Actos Bladder Cancer Lawsuit Long on Complexity
According to court documents, the Allens are suing both Takeda Pharmaceuticals Co. Inc. and Eli Lilly. While Takeda, the Japanese pharma giant, serves as the current manufacturer and marketer of record for Actos, the Allen Actos lawsuit holds that ...